Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Current Assets (2016 - 2026)

Champions Oncology (CSBR) has 15 years of Current Assets data on record, last reported at $21.3 million in Q4 2025.

  • For Q4 2025, Current Assets rose 51.46% year-over-year to $21.3 million; the TTM value through Oct 2025 reached $21.3 million, up 51.46%, while the annual FY2025 figure was $22.4 million, 63.93% up from the prior year.
  • Current Assets reached $21.3 million in Q4 2025 per CSBR's latest filing, up from $21.0 million in the prior quarter.
  • Across five years, Current Assets topped out at $22.4 million in Q2 2025 and bottomed at $12.6 million in Q3 2021.
  • Average Current Assets over 5 years is $16.8 million, with a median of $16.4 million recorded in 2022.
  • Peak YoY movement for Current Assets: soared 71.82% in 2021, then tumbled 35.17% in 2024.
  • A 5-year view of Current Assets shows it stood at $13.7 million in 2021, then soared by 50.4% to $20.6 million in 2022, then plummeted by 31.98% to $14.0 million in 2023, then rose by 0.48% to $14.1 million in 2024, then soared by 51.46% to $21.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $21.3 million in Q4 2025, $21.0 million in Q3 2025, and $22.4 million in Q2 2025.